Mario Family Funds, based in the United States, primarily invests in biotechnology startups that are 6-10 years old. The fund typically participates in investment rounds with 6 participants and prefers founders of portfolio startups. It has made notable investments in companies such as Femasys, Clinipace, and OrphoMed. The fund's key investment industries include Clinical Trials and Biotechnology, and it typically invests in rounds ranging from $10 to $50 million. In previous rounds, the fund has been co-financed by Harbert Growth Partners, Virgo Investment Group, and Perella Weinberg Partners, while Morgan Stanley Expansion Capital, Hatteras Venture Partners, and Harbert Growth Partners have been significant sponsors in the same investment rounds.